Literature DB >> 11899100

Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger.

Dun-xian Tan1, Russel J Reiter, Lucien C Manchester, Mei-ting Yan, Mamdouh El-Sawi, Rosa M Sainz, Juan C Mayo, Ron Kohen, Mario Allegra, Rudiger Hardeland.   

Abstract

Melatonin was found to be a potent free radical scavenger in 1993. Since then over 800 publications have directly or indirectly confirmed this observation. Melatonin scavenges a variety of reactive oxygen and nitrogen species including hydroxyl radical, hydrogen peroxide, singlet oxygen, nitric oxide and peroxynitrite anion. Based on the analyses of structure-activity relationships, the indole moiety of the melatonin molecule is the reactive center of interaction with oxidants due to its high resonance stability and very low activation energy barrier towards the free radical reactions. However, the methoxy and amide side chains also contribute significantly to melatonin's antioxidant capacity. The N-C=O structure in the C3 amide side chain is the functional group. The carbonyl group in the structure of N-C=O is key for melatonin to scavenge the second reactive species and the nitrogen in the N-C=O structure is necessary for melatonin to form the new five membered ring after melatonin's interaction with a reactive species. The methoxy group in C5 appears to keep melatonin from exhibiting prooxidative activity. If the methoxy group is replaced by a hydroxyl group, under some in vitro conditions, the antioxidant capacity of this molecule may be enhanced. However, the cost of this change are decreased lipophility and increased prooxidative potential. Therefore, in in vivo studies the antioxidant efficacy of melatonin appears to be superior to its hydroxylated counterpart. The mechanisms of melatonin's interaction with reactive species probably involves donation of an electron to form the melatoninyl cation radical or through an radical addition at the site C3. Other possibilities include hydrogen donation from the nitrogen atom or substitution at position C2, C4 and C7 and nitrosation. Melatonin also has the ability to repair damaged biomolecules as shown by the fact that it converts the guanosine radical to guanosine by electron transfer. Unlike the classical antioxidants, melatonin is devoid of prooxidative activity and all known intermediates generated by the interaction of melatonin with reactive species are also free radical scavengers. This phenomenon is defined as the free radical scavenging cascade reaction of the melatonin family. Due to this cascade, one melatonin molecule has the potential to scavenge up to 4 or more reactive species. This makes melatonin very effective as an antioxidant. Under in vivo conditions, melatonin is often several times more potent than vitamin C and E in protecting tissues from oxidative injury when compared at an equivalent dosage (micromol/kg). Future research in the field of melatonin as a free radical scavenger might be focused on: 1), signal transduction and antioxidant enzyme gene expression induced by melatonin and its metabolites, 2), melatonin levels in tissues and in cells, 3), melatonin structure modifications, 4), melatonin and its metabolites in plants and, 5), clinical trials using melatonin to treat free radical related diseases such as Alzheimer's, Parkinson's, stroke and heart disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11899100     DOI: 10.2174/1568026023394443

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  181 in total

1.  Differential effects of melatonin as a broad range UV-damage preventive dermato-endocrine regulator.

Authors:  Konrad Kleszczyński; Lena H Hardkop; Tobias W Fischer
Journal:  Dermatoendocrinol       Date:  2011-01

2.  Melatonin in aging and disease -multiple consequences of reduced secretion, options and limits of treatment.

Authors:  Rüdiger Hardeland
Journal:  Aging Dis       Date:  2011-02-10       Impact factor: 6.745

Review 3.  Reactive oxygen species in the regulation of synaptic plasticity and memory.

Authors:  Cynthia A Massaad; Eric Klann
Journal:  Antioxid Redox Signal       Date:  2010-10-28       Impact factor: 8.401

Review 4.  The circadian control of skin and cutaneous photodamage.

Authors:  Joshua A Desotelle; Melissa J Wilking; Nihal Ahmad
Journal:  Photochem Photobiol       Date:  2012-02-21       Impact factor: 3.421

Review 5.  Promising Role of Melatonin as Neuroprotectant in Neurodegenerative Pathology.

Authors:  Neeraj Joshi; Joyshree Biswas; C Nath; Sarika Singh
Journal:  Mol Neurobiol       Date:  2014-08-27       Impact factor: 5.590

Review 6.  Melatonin and nitric oxide: two required antagonists for mitochondrial homeostasis.

Authors:  Darío Acuña-Castroviejo; Germaine Escames; Luis C López; Ana B Hitos; Josefa León
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

7.  Supplementation with low concentrations of melatonin improves nuclear maturation of human oocytes in vitro.

Authors:  Duo Wei; Cuilian Zhang; Culian Zhang; Juanke Xie; Xiaobing Song; Baoli Yin; Qi Liu; Lin Hu; Haoying Hao; Jiaxuan Geng; Peng Wang
Journal:  J Assist Reprod Genet       Date:  2013-06-06       Impact factor: 3.412

8.  Effects of light at night on laboratory animals and research outcomes.

Authors:  Kathryn M Emmer; Kathryn L G Russart; William H Walker; Randy J Nelson; A Courtney DeVries
Journal:  Behav Neurosci       Date:  2018-06-28       Impact factor: 1.912

Review 9.  Melatonin as a mitochondria-targeted antioxidant: one of evolution's best ideas.

Authors:  Russel J Reiter; Sergio Rosales-Corral; Dun Xian Tan; Mei Jie Jou; Annia Galano; Bing Xu
Journal:  Cell Mol Life Sci       Date:  2017-09-01       Impact factor: 9.261

Review 10.  Extrapineal melatonin: sources, regulation, and potential functions.

Authors:  Darío Acuña-Castroviejo; Germaine Escames; Carmen Venegas; María E Díaz-Casado; Elena Lima-Cabello; Luis C López; Sergio Rosales-Corral; Dun-Xian Tan; Russel J Reiter
Journal:  Cell Mol Life Sci       Date:  2014-02-20       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.